Knowledge Industry Information Center R&D Information Center: Analysis of Advanced Biopharmaceutical Industry Outlook and Domestic and International Research Trends in New Drug Development

Global drug markets are expanding, with the weight of the global pharmaceutical industry moving from synthetic drugs to bio-drugs, as more aging and chronic patients around the world are increasing and health care is increasing as income levels in the country. The global drug market has grown to about a trillion dollars, and bio-drugs have grown to 20 percent for about $200 billion. Our interest in the future growth power industry is growing as the tidal ship, steel and other main power industries continue. While the weight of the pharmaceutical industry in the current domestic economy is not large and its association with other industries is not high, development of the drug system is essential for global breakthroughs. Global pharmaceutical companies, which maintain the annual revenue of hundreds of billions of dollars, have grown through global drug development and sales. According to a report from GN in 2017, eight of the 10 best-selling medicines in the world are bio-drugs. This growth trend is a prospect that will continue, and it supports the fact that many bio-chems have been approved in recent years before the new ones. The next generation of bio-drugs, cellular and gene therapy, is a future area that the domestic pharmaceutical industry is going to be trying to look for.

Korean title: 첨단 바이오의약품 산업전망과 신약개발 국내외 연구동향 분석

Korean author: 지식산업정보원 R&D정보센터

Korean publisher: 지식산업정보원

ISBN-13: 9791158620745